Get The Crypto Playbook for 2025
Keeping up with crypto while working a full-time job? Nearly impossible.
But Crypto is on fire and it’s not slowing down, with the industry having just hit a record-high $4 trillion dollar market cap.
And we’re sharing it at no cost when you subscribe to our free daily investment newsletter.
It covers the new Crypto bills that just passed and all the top trends, including the altcoin we think could define this cycle. That’s right, you can catch up on the industry in 5 minutes and still take advantage of this record bull run.
Skip the noise and stay one step ahead of the crypto and stock market.
Stocks & Income is for informational purposes only and is not intended to be used as investment advice. Do your own research.
THE MONEY IDEA💡
Don’t Miss These 4 Buys
Welcome, we are {{active_subscriber_count}} Money Masters and counting!
With the Fed easing and markets grinding higher, select mid-cap names still trade at steep discounts while the spotlight stays on mega-cap momentum. Morningstar experts highlighted four overlooked companies that combine resilient cash flows, undervalued multiples, and steady long-term growth drivers. These are the kinds of opportunities that can quietly compound before everyone else finally notices.
Let’s dive in.
THE MONEY IDEA💡
Don’t Miss These 4 Buys
Bottom Line: A wide-moat orthopedic franchise trading cheaply despite strong demographic tailwinds supporting durable long-term demand.
Discount Window – Shares rated 4 stars and 23% below fair value, creating room for multiple expansion.
Structural Demand – Aging boomers and active younger patients ensure steady growth in joint replacements.
Moat Strength – Entrenched relationships with hospitals and surgeons create high switching costs.
Conservative Model – Morningstar assumes only 3.5% revenue CAGR, leaving upside if growth exceeds.
Margin Potential – Management’s 30% operating margin long-term target compares with 28% modeled, leaving conservative room for upside.
Do This Next: Build a core stake and track progress toward operating margin expansion targets.
Bottom Line: A tower REIT with stable cash flows and a near-5% dividend, poised to benefit if rates trend lower.
Dividend Power – A 4.6% yield offers dependable income in an otherwise volatile market.
Discounted – Shares rated 4 stars and 25% below fair value after selling off on rising yields.
Rate Sensitivity – Stock tends to rebound strongly when long-term Treasury yields drift lower.
Asset Base – Wireless tower portfolio benefits from scale advantages and sticky customer contracts.
Volatility Note – More volatile than typical REITs, giving opportunistic investors multiple entry points.
Do This Next: Accumulate on dips and reinvest dividends to compound long-term returns.
Bottom Line: A narrow-moat medical supplier working through execution issues, with long-term recovery potential as margins normalize and investor confidence rebuilds.
Valuation Reset – Stock trades at a 31% discount to fair value, giving investors a wide margin of safety.
Execution Check – Revenue growth turned positive last quarter and EPS guidance was raised for the year.
Portfolio Refocus – Partnerships in diagnostics allow sharper focus on core medtech operations and efficiency.
Investor Sentiment – Years of underperformance left many institutions light on exposure, setting up asymmetric rebound potential.
Margin Path – As the business stabilizes, mid-single-digit revenue growth could drive double-digit profit expansion.
Do This Next: Accumulate gradually and reassess if guidance gains credibility across multiple quarters.
Bottom Line: A wide-moat leader in network security regaining ground after an earnings miss, with long-term growth driven by cloud adoption and enterprise resilience.
Discount Entry – Shares rated 4 stars and 22% below fair value after a selloff tied to slower hardware sales.
Growth Runway – Expansion into secure access service edge and security operations is compounding 20–30% annually off smaller bases.
Moat Strength – Deep customer integration creates high switching costs while its installed base expands network effects.
Earnings Leverage – Forecasts call for 13%+ revenue CAGR with nearly 16% EPS growth over the next five years.
Forward Lens – Current 31x multiple compresses to ~26x on 2026 earnings, offering valuation relief as growth compounds.
Do This Next: Initiate a position and add incrementally on volatility around earnings reports.
ACTION PLAN✅
Let’s Make Money Today!
Quick Money: Mid caps are catching renewed interest as the easing cycle unfolds. Begin with iShares Core S&P Mid-Cap ETF $IJH ( ▲ 1.02% ) and then layer in targeted positions where valuations remain compelling.
$ZBH ( ▲ 1.31% ): Build a long-term position with demographic tailwinds supporting steady demand.
$CCI ( ▲ 1.42% ): Buy on rate-driven weakness, let dividend reinvestment amplify total return.
$BDX ( ▲ 2.22% ): Accumulate on weakness, tracking execution milestones and guidance credibility.
$FTNT ( ▲ 1.33% ): Initiate and add on pullbacks as growth in SASE and SecOps scales into results.
If you’re looking for more smart, actionable ideas beyond this week’s picks, we’ve gathered a short list of other high-quality newsletters worth your time.
See our curated picks here — practical insights on money, work, and life from trusted sources.
Get the Certificate That Opens Doors in Private Equity
Gain the skills top professionals use to analyze PE investment opportunities.
Over 8 weeks, learn directly from Wharton faculty and senior leaders at Carlyle, Blackstone, and KKR.
Join 5,000+ graduates worldwide, earn a respected certificate, and save $300 with code SAVE300 at checkout.
The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.